Abstract
10x Genomics and PerkinElmer plan to jointly offer automated next-generation sequencing (NGS) solutions, by combining 10x’s sequencing platform with PerkinElmer’s automation solutions. The result, the companies says, will aid researchers with a streamlined and enhanced NGS workflow.
“Our collaboration with Perkin-Elmer underscores 10x’s commitment to advancing the way we look at and understand genetic information,” says Serge Saxonov, co-founder and CEO of 10x Genomics. “As genomic research becomes more and more prominent, access to 10x solutions will illuminate a more comprehensive understanding of disease.”
Under the agreement, PerkinElmer will develop automation protocols for use with the 10x Genomics Chromium System, 10x’s core technology. It requires only small fragments of DNA (approximately 1 ng) to deliver long-range sequence information, perform haplotype phasing, and reveal structural genomic variation, in addition to other genomic content.
“This relationship with 10x Genomics will enhance the PerkinElmer automation menu and help progress researchers’ interpretation of some of the most important biological questions through increased sequence information and insights into the complexity of the genome,” says Prahlad Singh, senior vp and president of diagnostics, PerkinElmer.
Colorized scanning electron micrograph of a natural killer cell from a human donor.
NIAID / Creative Commons
